Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain

ClinicalTrials.gov ID: NCT01032837

Public ClinicalTrials.gov record NCT01032837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter Trial of Oseltamivir [Tamiflu] Doses of 75 mg for 5 or 10 Days Versus 150 mg for 5 or 10 Days to Evaluate the Effect on the Duration of Viral Shedding in Influenza Patients With Pandemic (H1N1) 2009

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, double-blind, multi-center study of Tamiflu (Oseltamivir) will evaluate the efficacy against viral activity, the effectiveness in resolving the disease symptoms, and the safety and tolerability in patients with influenza. Patients with (H1N1) 2009 influenza strain or influenza A are eligible for this study. Patients will be randomized to one of four treatment regimens. Patients will receive oral doses of either 75 mg (adults) or 150 mg (adults) of study drug twice daily for 5 or 10 consecutive days. The dose will be body weight-adjusted for pediatric patients.

Study identification

NCT ID
NCT01032837
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
102 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Year and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2009
Primary completion
Sep 30, 2010
Completion
Sep 30, 2010
Last update posted
Oct 1, 2012

2009 – 2010

United States locations

U.S. sites
100
U.S. states
33
U.S. cities
94
Facility City State ZIP Site status
Not listed Tuscaloosa Alabama 35406
Not listed Phoenix Arizona 85016
Not listed Phoenix Arizona 85050
Not listed Scottsdale Arizona 85248
Not listed Jonesboro Arkansas 72401
Not listed Carmichael California 95608
Not listed Downey California 90241
Not listed Fountain Valley California 92708
Not listed Huntington Beach California 92647
Not listed Lomita California 90717
Not listed National City California 91950
Not listed Paramount California 90723
Not listed Sacramento California 95823
Not listed San Diego California 92103-6204
Not listed San Diego California 92120
Not listed Colorado Springs Colorado 80909
Not listed DeLand Florida 32720
Not listed Fleming Island Florida 32003
Not listed Gainesville Florida 32607
Not listed Jacksonville Florida 32205
Not listed Largo Florida 33770
Not listed Miami Florida 33126
Not listed Miami Florida 33135
Not listed Orlando Florida 32806
Not listed Pembroke Pines Florida 33026
Not listed Saint Cloud Florida 34769
Not listed Atlanta Georgia 30342
Not listed Idaho Falls Idaho 83404
Not listed Meridian Idaho 83642
Not listed Chicago Illinois 60622
Not listed Indianapolis Indiana 46268
Not listed Newburgh Indiana 47630
Not listed Dubuque Iowa 52002
Not listed Overland Park Kansas 66210
Not listed Bardstown Kentucky 40004
Not listed Madisonville Kentucky 42431
Not listed Lake Charles Louisiana 70601
Not listed Mandeville Louisiana 70471
Not listed Meltairie Louisiana 70006
Not listed Shreveprt Louisiana 71106
Not listed Brockton Massachusetts 02301
Not listed Stevensville Michigan 49127
Not listed Bridgeton Missouri 63044
Not listed St Louis Missouri 63141
Not listed Bozeman Montana 59715
Not listed Bellevue Nebraska 68005
Not listed Freemont Nebraska 68025
Not listed Haddon Heights New Jersey 08035
Not listed Sicklerville New Jersey 08081
Not listed Camillus New York 13031
Not listed Endwell New York 13780
Not listed Johnson City New York 13790
Not listed Asheboro North Carolina 27203
Not listed Burlington North Carolina 27215
Not listed Greensboro North Carolina 27408
Not listed Harrisburg North Carolina 28075
Not listed Mooresville North Carolina 28117
Not listed Morganton North Carolina 28655
Not listed Raleigh North Carolina 27612
Not listed Salisbury North Carolina 28144
Not listed Bismarck North Dakota 58501
Not listed Canal Fulton Ohio 44614
Not listed Cincinnati Ohio 45219
Not listed Cleveland Ohio 44121
Not listed Cleveland Ohio 44122
Not listed Oklahoma City Oklahoma 73112
Not listed Ashland Oregon 97520
Not listed Medford Oregon 97504
Not listed Collegeville Pennsylvania 19426
Not listed Erie Pennsylvania 16506
Not listed Jefferson Hills Pennsylvania 15025
Not listed Pittsburgh Pennsylvania 15236
Not listed Pittsburgh Pennsylvania 15241
Not listed Reading Pennsylvania 19606
Not listed Scotland Pennsylvania 17254
Not listed Upland Pennsylvania 19013
Not listed Charleston South Carolina 29412
Not listed Mt. Pleasant South Carolina 29464
Not listed Simpsonville South Carolina 29681
Not listed Bristol Tennessee 37620
Not listed Jackson Tennessee 38305
Not listed Johnson City Tennessee 37604
Not listed Kingsport Tennessee 37660
Not listed Bedford Texas 76022
Not listed Corpus Christi Texas 78411
Not listed Dallas Texas 75220
Not listed El Paso Texas 79912
Not listed Fort Worth Texas 76109
Not listed New Braunfels Texas 78130
Not listed San Antonio Texas 78215
Not listed San Antonio Texas 78238
Not listed Tomball Texas 77375
Not listed Clinton Utah 84015
Not listed Magna Utah 84044
Not listed Salt Lake City Utah 84107
Not listed Saratoga Springs Utah 84045
Not listed West Jordan Utah 84088
Not listed Richmond Virginia 23219
Not listed Vienna Virginia 22180
Not listed Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01032837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01032837 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →